114 related articles for article (PubMed ID: 27641227)
1. Prevalence and clinical aspects of immigrants with myasthenia gravis in northern Europe.
Boldingh MI; Maniaol A; Brunborg C; Dekker L; Lipka A; Niks EH; Verschuuren J; Tallaksen C
Muscle Nerve; 2017 Jun; 55(6):819-827. PubMed ID: 27641227
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands.
Niks EH; Kuks JB; Verschuuren JJ
J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):417-8. PubMed ID: 17056627
[TBL] [Abstract][Full Text] [Related]
3. Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis.
Jordan B; Schilling S; Zierz S
J Neurol; 2016 Jan; 263(1):174-6. PubMed ID: 26645394
[No Abstract] [Full Text] [Related]
4. Acquired myasthenia gravis in childhood.
Evoli A
Curr Opin Neurol; 2010 Oct; 23(5):536-40. PubMed ID: 20581680
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of patients with Myasthenia gravis from the Henan province, China.
Gao F; Zhao X; Zhang J; Cui X; Zhang Y; Li Q; Liu P; Fang H; Du Y; Zhang Q; Yang J; Zhang Y
Muscle Nerve; 2016 May; 53(5):711-6. PubMed ID: 26403759
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
[TBL] [Abstract][Full Text] [Related]
7. Effect of ethnic origin and gender on the clinical manifestations of myasthenia gravis among the Jewish population in Israel.
Asmail A; Kesler A; Drory VE; Kolb H; Karni A
J Neuroimmunol; 2017 Jun; 307():47-52. PubMed ID: 28495138
[TBL] [Abstract][Full Text] [Related]
8. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
[TBL] [Abstract][Full Text] [Related]
9. Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?
Choi Decroos E; Hobson-Webb LD; Juel VC; Massey JM; Sanders DB
Muscle Nerve; 2014 Jan; 49(1):30-4. PubMed ID: 23625360
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of myasthenic crisis after thymectomy for thymoma patients with myasthenia gravis.
Xue L; Wang L; Dong J; Yuan Y; Fan H; Zhang Y; Wang Q; Ding J
Eur J Cardiothorac Surg; 2017 Oct; 52(4):692-697. PubMed ID: 29156018
[TBL] [Abstract][Full Text] [Related]
11. Geographical Distribution of Myasthenia Gravis in Northern Europe--Results from a Population-Based Study from Two Countries.
Boldingh MI; Maniaol AH; Brunborg C; Dekker L; Heldal AT; Lipka AF; Popperud TH; Niks EH; Verschuuren JJ; Tallaksen CM
Neuroepidemiology; 2015; 44(4):221-31. PubMed ID: 26068011
[TBL] [Abstract][Full Text] [Related]
12. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic myasthenia gravis: immunological and clinical aspects.
Skeie GO; Romi F
Eur J Neurol; 2008 Oct; 15(10):1029-33. PubMed ID: 18717725
[TBL] [Abstract][Full Text] [Related]
14. [Thymoma-associated myasthenia gravis: Clinical features and surgical results].
Bouchikh M; El Malki HO; Ouchen F; Achir A; Benosman A
Rev Neurol (Paris); 2013 Nov; 169(11):879-83. PubMed ID: 23639728
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, clinical features and treatment outcomes of patients with myasthenia gravis positive for antibodies to muscle-specific kinase in Thailand.
Witoonpanich R; Dejthevaporn C; Pulkes T; Tunlayadechanont S; Boonkongchuen P; Pongpakdee S; Vincent A
J Clin Neurosci; 2013 May; 20(5):707-9. PubMed ID: 23352351
[TBL] [Abstract][Full Text] [Related]
16. The features of myasthenia gravis with autoantibodies to MuSK.
Lavrnic D; Losen M; Vujic A; De Baets M; Hajdukovic LJ; Stojanovic V; Trikic R; Djukic P; Apostolski S
J Neurol Neurosurg Psychiatry; 2005 Aug; 76(8):1099-102. PubMed ID: 16024887
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases.
Santos E; Coutinho E; Moreira I; Silva AM; Lopes D; Costa H; Silveira F; Nadais G; Morais H; Martins J; Branco MC; Veiga A; Silva RS; Ferreira A; Sousa F; Freijo M; Matos I; André R; Negrão L; Fraga C; Santos M; Sampaio M; Lopes C; Leite MI; Gonçalves G
Muscle Nerve; 2016 Sep; 54(3):413-21. PubMed ID: 26851892
[TBL] [Abstract][Full Text] [Related]
18. Prior damage to lower motor neuron triggering myasthenia gravis.
Steiner I; Goldstein L; Hellmann MA; Lotan I
Muscle Nerve; 2016 Jun; 54(1):167-9. PubMed ID: 26789735
[No Abstract] [Full Text] [Related]
19. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.
Zisimopoulou P; Evangelakou P; Tzartos J; Lazaridis K; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Frenkian Cuvelier M; Stojkovic T; DeBaets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Tzartos SJ
J Autoimmun; 2014 Aug; 52():139-45. PubMed ID: 24373505
[TBL] [Abstract][Full Text] [Related]
20. Three cases of myasthenia gravis from one family with variations in clinical features and serum antibodies.
Chen Y; Wang W; Wei D; Yang L
Neuromuscul Disord; 2012 Mar; 22(3):286-8. PubMed ID: 22082588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
